Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|||
| Income Statement [Abstract] | ||||
| Revenue | ||||
| Operating expenses: | ||||
| Sales and marketing | 1,387 | 385 | ||
| General and administrative | 3,375 | 2,240 | ||
| Research and development | 3,315 | 2,628 | ||
| Total operating expenses | 8,077 | 5,253 | ||
| Loss from operations | (8,077) | (5,253) | ||
| Other income (expense): | ||||
| Interest expense | (52) | |||
| Change in fair value - Senior Secured Convertible Notes and Senior Convertible Note | 1,682 | (8,008) | ||
| Offering costs - Senior Secured Convertible Note and Senior Convertible Note | (410) | |||
| Debt extinguishments loss - Senior Secured Convertible Notes | (3,715) | (1,188) | ||
| Other income (expense), net | (2,033) | (9,658) | ||
| Loss before provision for income tax | (10,110) | (14,911) | ||
| Provision for income taxes | ||||
| Net loss before noncontrolling interests | (10,110) | (14,911) | ||
| Net loss attributable to the noncontrolling interests | 679 | 436 | ||
| Net loss attributable to PAVmed Inc. | (9,431) | (14,475) | ||
| Less: Series B Convertible Preferred Stock dividends earned | (75) | (70) | ||
| Net loss attributable to PAVmed Inc. common stockholders | $ (9,506) | $ (14,545) | ||
| Per share information: | ||||
| Net loss per share attributable to PAVmed Inc. - basic and diluted | $ (0.13) | $ (0.33) | ||
| Net loss per share attributable to PAVmed Inc. common stockholders - basic and diluted | $ (0.13) | $ (0.33) | ||
| Weighted average common shares outstanding, basic and diluted | [1] | 73,954,126 | 43,499,714 | |
| ||||
| X | ||||||||||
- Definition Change in fair value senior secured convertible note. No definition available.
|
| X | ||||||||||
- Definition Net loss attributable to common stockholders per share - basic and diluted. No definition available.
|
| X | ||||||||||
- Definition Offering costs - Senior Secured Convertible Note and Senior Convertible Note. No definition available.
|
| X | ||||||||||
- Definition Series B Convertible Preferred Stock dividends earned. No definition available.
|
| X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). No definition available.
|